SCM
Sarissa Capital Management Portfolio holdings
AUM
$154M
This Quarter Return
+2.8%
1 Year Return
-6.05%
3 Year Return
-7.91%
5 Year Return
+32.47%
10 Year Return
+262.41%
AUM
$798M
AUM Growth
+$798M
(-0.53%)
Cap. Flow
+$12.5M
Cap. Flow
% of AUM
1.57%
Top 10 Holdings %
Top 10 Hldgs %
99.98%
Holding
13
New
–
Increased
3
Reduced
–
Closed
1
Top Buys
| 1 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$6.24M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
$5.83M |
| 3 |
Ironwood Pharmaceuticals
IRWD
|
$3.31M |
Top Sells
| 1 |
Cyclerion Therapeutics
CYCN
|
$2.86M |
Sector Composition
| 1 | Healthcare | 73.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDCO
1
DELISTED
Medicines Co
MDCO
| $210M | 26.33% | 4,202,000 | – | – |
|
|
AGN
2
DELISTED
Allergan plc
AGN
| $175M | 21.99% | 1,042,500 | – | – |
|
3
Biogen
BIIB
$19.4B
| $150M | 18.76% | 643,000 | – | – |
|
|
4
Ironwood Pharmaceuticals
IRWD
$214M
| $86.7M | 10.87% | 10,103,000 +385,000 | +4% | +$3.31M |
|
5
Innoviva
INVA
$1.29B
| $65.8M | 8.25% | 6,242,000 | – | – |
|
|
ICPT
6
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $56.5M | 7.08% | 851,000 +94,000 | +12% | +$6.24M |
|
|
7
Jazz Pharmaceuticals
JAZZ
$7.75B
| $31M | 3.89% | 242,000 +45,500 | +23% | +$5.83M |
|
8
Puma Biotechnology
PBYI
$254M
| $15.3M | 1.91% | 1,417,000 | – | – |
|
9
Mersana Therapeutics
MRSN
$36.5M
| $5.93M | 0.74% | 3,750,000 | – | – |
|
|
RGLS
10
DELISTED
Regulus Therapeutics
RGLS
| $1.33M | 0.17% | 1,851,851 | – | – |
|
|
MRTX
11
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $77K | 0.01% | 1,000 | – | – |
|
12
AbbVie
ABBV
$372B
| $75K | 0.01% | 1,000 | – | – |
|
|
13
Cyclerion Therapeutics
CYCN
$7.91M
| – | – | -250,000 | Closed | -$2.86M |
|